TranspariMED clinical trial transparency

8 May 2017

New study documents how the lack of clinical trials transparency harms patients, taxpayers and investors, based on six in-depth case studies.

6 Mar 2017

The European Medicines Agency (EMA) in February 2017 launched a public consultation on the proposed revision to its policy on access to documents. The new version extends the scope of the EMA’s existing policy and includes new access rules for corporate documents held by the EMA, and new access rules for documents related to medicines for human and veterinary use held by the EM...

Please reload

Recent Posts
Please reload

This site was designed with the
website builder. Create your website today.
Start Now